Suppr超能文献

改良强制性运动疗法治疗缺血性脑卒中下肢神经后遗症后早期血清 ACSL4 和 ASITN/SIR 分级对运动功能恢复的预测价值。

Predictive value of early serum ACSL4 and ASITN/SIR grade for motor function recovery in patients with post-ischemic stroke lower limb neurological sequelae after modified constraint-induced movement therapy.

机构信息

Department of Rehabilitation, The Second Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.

Department of Rehabilitation, Xiangya Hospital, Central South University, Changsha, Hunan, China.

出版信息

Clin Neurol Neurosurg. 2024 Oct;245:108464. doi: 10.1016/j.clineuro.2024.108464. Epub 2024 Jul 26.

Abstract

BACKGROUND

Ischemic stroke accounts for over 85 % of all stroke types. Acyl-CoA synthetase long chain family member 4 (ACSL4) is considered to promote myocardial and cerebral ischaemia/ reperfusion. However, up to now, no study focused on the role of ACSL4 in patients with post-stroke lower limb neurological sequelae.

OBJECTIVE

The present study aimed to investigate the predictive value of ACSL4 and collateral circulation for lower limb neurological sequelae of ischemic stroke patients after modified constraint-induced movement therapy (mCIMT).

METHODS

This is a prospective cohort study which included 99 ischemic stroke patients with lower limb neurological sequelae who were admitted to our hospital during January 2021 to December 2022. All patients received mCIMT after the admission. Collateral circulation was evaluated by digital subtraction angiography (DSA) and graded by the American Society of Interventional and Therapeutic Neuroradiology/ Society of Interventional Radiology (ASITN/SIR) grading system. Enzyme linked immunosorbent assay (ELISA) was used to detect serum ACSL4. Basic characteristics were collected and lower limb motor function was measured by Fugl-Meyer score (FMS), modified Ashworth score (MAS) and Brunnstrom stage, as well as timed up and go (TUG) test, ten-Meter walk test (10MWT), and six-minute walk test (6MWT) before and after treatment.

RESULTS

Serum ACSL4 and percentage of patients with ASITN/SIR 0-1 decreased significantly after treatment compared with the values before treatment. Patients with higher baseline serum ACSL4 values at admission showed significantly lower FMS scores, higher TUG and 10MWT, as well as lower 6MWT. Patients with ASITN/SIR grade 0-1 at admission only showed significantly higher TUG and 10MWT, as well as lower 6MWT. Receiver operating characteristic (ROC) curves showed ACSL4 and ASITN/SIR grade could be used to predict the prognosis. Logistic regression found only national institutes of health stroke scores (NIHSS) was the independent risk factor for post-treatment motor impairment after mCIMT.

CONCLUSION

Higher levels of ACSL4 and ASITN/SIR 0-1 are associated with poor recovery of motor functions of patients with post-stroke sequelae after mCIMT.

摘要

背景

缺血性脑卒中占所有脑卒中类型的 85%以上。酰基辅酶 A 合成酶长链家族成员 4(ACSL4)被认为可促进心肌和脑缺血/再灌注。然而,到目前为止,尚无研究关注 ACSL4 在脑卒中后下肢神经后遗症患者中的作用。

目的

本研究旨在探讨酰基辅酶 A 合成酶长链家族成员 4(ACSL4)和侧支循环对改良强制性运动疗法(mCIMT)后缺血性脑卒中患者下肢神经后遗症的预测价值。

方法

这是一项前瞻性队列研究,纳入了 2021 年 1 月至 2022 年 12 月期间我院收治的 99 例缺血性脑卒中后下肢神经后遗症患者。所有患者入院后均接受 mCIMT。通过数字减影血管造影(DSA)评估侧支循环,并采用美国介入治疗和神经放射治疗学会/介入放射学学会(ASITN/SIR)分级系统进行分级。酶联免疫吸附试验(ELISA)用于检测血清 ACSL4。收集基本特征,并在治疗前后采用 Fugl-Meyer 评分(FMS)、改良 Ashworth 评分(MAS)和 Brunnstrom 分期以及计时起立行走测试(TUG)、10 米步行测试(10MWT)和 6 分钟步行测试(6MWT)测量下肢运动功能。

结果

与治疗前相比,治疗后血清 ACSL4 和 ASITN/SIR 0-1 级患者的比例明显下降。入院时血清 ACSL4 基线值较高的患者,FMS 评分较低,TUG 和 10MWT 较高,6MWT 较低。入院时 ASITN/SIR 分级 0-1 级的患者仅 TUG 和 10MWT 较高,6MWT 较低。受试者工作特征(ROC)曲线显示,ACSL4 和 ASITN/SIR 分级可用于预测预后。Logistic 回归发现,只有国立卫生研究院卒中量表(NIHSS)是 mCIMT 后运动功能障碍的独立危险因素。

结论

较高的 ACSL4 水平和 ASITN/SIR 0-1 级与 mCIMT 后脑卒中后患者运动功能恢复不良有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验